ImageneBio Inc(IMA)

Biotechnology · San Diego, CA

$4.76+0.05 (+1.17%)

Delayed quote: Oct 6, 2026, 12:31 PM EDT

Operating Cash Flow Yield: N/A

Basis: Four-quarter operating cash flow / FMP quote market capitalization × 100. Source: stored company filings and market data; unavailable inputs remain N/A.

The operating cash flow yield is N/A as of 2026-10-06T17:02:44.062Z.

Stored calculation inputs

Calculation as of: 2026-10-06T17:02:44.062Z.

Quote observation: 2026-10-06T16:31:24.000Z. Amounts in USD. The price header may show a later quote.

TTM operating cash flow · period ending 2026-06-30: -57,733,000
Quote market capitalization: 53,632,121

FMP input reference: 3f3fe5cfad96663d45aee285232b63282d401ce5a2dce1ebe999e7f7af3a8937

P/OCF Ratio|FCF Yield|Earnings Yield|EBITDA Yield|All Metrics

Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.

IMA Operating Cash Flow Yield Metrics

OPERATING CASH FLOW YIELD

N/A

IMA Competitors' Operating Cash Flow Yield

IMA

ImageneBio Inc

Current

Market Cap

$53.63M

Operating Cash Flow Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

ALDX

Aldeyra The

vs IMA

Market Cap

$53.50M

Operating Cash Flow Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

MDAI

Spectral AI, Inc.

vs IMA

Market Cap

$53.46M

Operating Cash Flow Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

NMAD

NOMAD Power Solutions, Inc.

vs IMA

Market Cap

$52.47M

Operating Cash Flow Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

BTMD

biote Corp.

vs IMA

Market Cap

$51.61M

Operating Cash Flow Yield

47.22%

TTM Avg

50.32%

3Y Avg

31.17%

5Y Avg

36.60%

EXOZ

eXoZymes, Inc.

vs IMA

Market Cap

$51.42M

Operating Cash Flow Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

RANI

Rani Therapeutics Holdings, Inc.

vs IMA

Market Cap

$51.38M

Operating Cash Flow Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

COCH

Envoy Medical, Inc.

vs IMA

Market Cap

$51.33M

Operating Cash Flow Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

CELU

Celularity Inc.

vs IMA

Market Cap

$50.80M

Operating Cash Flow Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

CLNN

Clene Inc.

vs IMA

Market Cap

$50.54M

Operating Cash Flow Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

NAME	MARKET CAP	OPERATING CASH FLOW YIELD	TTM	3Y	5Y
ImageneBio Inc (IMA)	$53.63M	N/A	N/A	N/A	N/A
Aldeyra The (ALDX)vs ›	$53.50M	N/A	N/A	N/A	N/A
Spectral AI, Inc. (MDAI)vs ›	$53.46M	N/A	N/A	N/A	N/A
NOMAD Power Solutions, Inc. (NMAD)vs ›	$52.47M	N/A	N/A	N/A	N/A
biote Corp. (BTMD)vs ›	$51.61M	47.22%	50.32%	31.17%	36.60%
eXoZymes, Inc. (EXOZ)vs ›	$51.42M	N/A	N/A	N/A	N/A
Rani Therapeutics Holdings, Inc. (RANI)vs ›	$51.38M	N/A	N/A	N/A	N/A
Envoy Medical, Inc. (COCH)vs ›	$51.33M	N/A	N/A	N/A	N/A
Celularity Inc. (CELU)vs ›	$50.80M	N/A	N/A	N/A	N/A
Clene Inc. (CLNN)vs ›	$50.54M	N/A	N/A	N/A	N/A

Operating Cash Flow Yield Formula & Definition

OCF Yield = TTM Operating Cash Flow / Market Cap

Operating cash flow yield is the inverse of P/OCF, expressing trailing operating cash flow as a percentage of price. It sits between earnings yield (before non-cash accrual effects) and FCF yield (before capital expenditure).

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

Operating Cash Flow Yield: N/A

IMA Operating Cash Flow Yield Metrics

IMA Competitors' Operating Cash Flow Yield

Operating Cash Flow Yield Formula & Definition

Related Metrics